Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
Clinical trial NCT03377725 · WITHDRAWN
Trial details
- NCT number
- NCT03377725
- Sponsor
- Li Junmin
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2018-03-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.